Xi Han Wu
Directeur Général chez Zhejiang Sunovo Pharmaceutical Co., Ltd.
Fortune : 3 M $ au 30/04/2024
Profil
Xi Han Wu is the founder of PharmaBlock Sciences (Nanjing), Inc., which was founded in 2006.
Dr. Wu held the titles of Secretary, Chief Technology Officer, and Deputy GM at PharmaBlock Sciences (Nanjing), Inc. Currently, Dr. Wu is the Chairman and General Manager at Zhejiang Sunovo Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2023 | 752 953 ( 0,45% ) | 3 M $ | 30/04/2024 |
Postes actifs de Xi Han Wu
| Sociétés | Poste | Début |
|---|---|---|
Zhejiang Sunovo Pharmaceutical Co., Ltd.
 Zhejiang Sunovo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China. | Directeur Général | - |
Anciens postes connus de Xi Han Wu
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Fondateur | 14/11/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| PharmaBlock Sciences (Nanjing), Inc. | |
Zhejiang Sunovo Pharmaceutical Co., Ltd.
Zhejiang Sunovo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China. | Health Technology |